SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-011062
Filing Date
2021-08-10
Accepted
2021-08-10 07:16:10
Documents
45
Period of Report
2021-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgtx-20210810x8k.htm   iXBRL 8-K 40690
2 EX-99.1 sgtx-20210810xex99d1.htm EX-99.1 189084
3 EX-99.2 sgtx-20210810xex99d2.htm EX-99.2 47311
4 GRAPHIC sgtx-20210810xex99d1001.jpg GRAPHIC 5781
5 GRAPHIC sgtx-20210810xex99d2g001.jpg GRAPHIC 172030
6 GRAPHIC sgtx-20210810xex99d2g002.jpg GRAPHIC 244056
7 GRAPHIC sgtx-20210810xex99d2g003.jpg GRAPHIC 109069
8 GRAPHIC sgtx-20210810xex99d2g004.jpg GRAPHIC 122377
9 GRAPHIC sgtx-20210810xex99d2g005.jpg GRAPHIC 154990
10 GRAPHIC sgtx-20210810xex99d2g006.jpg GRAPHIC 157820
11 GRAPHIC sgtx-20210810xex99d2g007.jpg GRAPHIC 124836
12 GRAPHIC sgtx-20210810xex99d2g008.jpg GRAPHIC 145352
13 GRAPHIC sgtx-20210810xex99d2g009.jpg GRAPHIC 156253
14 GRAPHIC sgtx-20210810xex99d2g010.jpg GRAPHIC 153644
15 GRAPHIC sgtx-20210810xex99d2g011.jpg GRAPHIC 119858
16 GRAPHIC sgtx-20210810xex99d2g012.jpg GRAPHIC 149642
17 GRAPHIC sgtx-20210810xex99d2g013.jpg GRAPHIC 121870
18 GRAPHIC sgtx-20210810xex99d2g014.jpg GRAPHIC 137839
19 GRAPHIC sgtx-20210810xex99d2g015.jpg GRAPHIC 140412
20 GRAPHIC sgtx-20210810xex99d2g016.jpg GRAPHIC 134001
21 GRAPHIC sgtx-20210810xex99d2g017.jpg GRAPHIC 136332
22 GRAPHIC sgtx-20210810xex99d2g018.jpg GRAPHIC 166459
23 GRAPHIC sgtx-20210810xex99d2g019.jpg GRAPHIC 157978
24 GRAPHIC sgtx-20210810xex99d2g020.jpg GRAPHIC 128444
25 GRAPHIC sgtx-20210810xex99d2g021.jpg GRAPHIC 125582
26 GRAPHIC sgtx-20210810xex99d2g022.jpg GRAPHIC 117018
27 GRAPHIC sgtx-20210810xex99d2g023.jpg GRAPHIC 100875
28 GRAPHIC sgtx-20210810xex99d2g024.jpg GRAPHIC 124473
29 GRAPHIC sgtx-20210810xex99d2g025.jpg GRAPHIC 135899
30 GRAPHIC sgtx-20210810xex99d2g026.jpg GRAPHIC 150650
31 GRAPHIC sgtx-20210810xex99d2g027.jpg GRAPHIC 125854
32 GRAPHIC sgtx-20210810xex99d2g028.jpg GRAPHIC 138420
33 GRAPHIC sgtx-20210810xex99d2g029.jpg GRAPHIC 138915
34 GRAPHIC sgtx-20210810xex99d2g030.jpg GRAPHIC 28063
  Complete submission text file 0001558370-21-011062.txt   6114322

Data Files

Seq Description Document Type Size
35 EX-101.SCH sgtx-20210810.xsd EX-101.SCH 3033
36 EX-101.LAB sgtx-20210810_lab.xml EX-101.LAB 16737
37 EX-101.PRE sgtx-20210810_pre.xml EX-101.PRE 10611
38 EXTRACTED XBRL INSTANCE DOCUMENT sgtx-20210810x8k_htm.xml XML 5053
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39746 | Film No.: 211158412
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences